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that year, but subsequent work identified it as nicotinamide,
part of the vitamin B complex.
Sir Hans Adolf Krebs (b. 1900) was a German-born
refugee from Nazism who became Professor of Biochemistry
at Oxford University. He shared the Nobel prize for medicine
and physiology in 1953 with Fritz Albert Lipmann (b.
1899), who had been a research worker at the Kaiser Wilhelm
Institute in Berlin and was also a refugee from the Nazis; he
held professorships at Harvard and the Rockefeller Institute.
Krebs discovered the tricarboxylic acid cycle (Krebs cycle), a
process by which foodstuffs are converted in the living cell to
carbon dioxide, water and energy. He was knighted in 1958.
Lipmann's share in the Nobel prize was for his discovery of
co-enzyme A and its role in the Krebs cycle.
Sir Ernst Boris Chain (1906-1979) shared the Nobel prize
for medicine in 1945 with Sir Alexander Fleming (1881-
1955), a bacteriologist at St Mary's Hospital, London, and Sir
Howard Walter Florey (b. 1898), a professor of pathology at
Oxford University. They evolved penicillin, the' first anti-
bacterial substance and an antibiotic still freely used today. Its
evolution took 16 years from Fleming's initial observation in
1928 that a Penicillium mould contaminating a culture plate of
Staphylococcus liquified the colonies. Sensing that an exuact of
the mould could be used in ueatment, Fleming attempted to
prepare an effective extract bur failed and gave up in 1932.
Fortunately in 1929 he had published his findings - as a
laboratory curiosity - in the Brirish Journal of Experimencal
Parhology. This article was notIced in 1938 by Chain,S who
was a Ph.D. graduate in biochemistry from Berlin and a
refugee from Nazi Germany then working in Florey's depart-
ment at Oxford. Chain was given the task of investigating
possible antibacterial substances of microbial origin. Obtaining
the original Penicillium suain from Fleming, the Oxford team
were able to prepare a crude exuact that protected mice
against pneumonia but they could not adequately purify the
exuact for use in man since the usual methods of exuaction
inactivated the penicillin. After 3 years of work under difficult
war-time conditions, Chain succeeded using a chromatographic
process to purify penicillin; this was proved to be effective
clinically. Fleming, Florey and Chain received knighthoods.
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Pregnancy without ovarian function
A case report
K. WISWEDEL, C. NORTH, P. BAILLlE
Summary
A 38-year-old nulliparous woman suffering from premature
menopause was stimulated with oestradiol valerate in order
to create an artificial endometrial cycle. Three oocytes were
donated by a woman on an in vitro fertilisation cycle and
were inseminated with the patient's husband's sperm. These
were then transferred into the patient's uterus after the endo-
metrium had been primed with progesterone to change it to
the secretory phase. Pregnancy resulted and proceeded well.
Gestation was terminated at the 34th week by caesarean
section and 2 healthy boys and 1 girl were delivered.
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Oocyte donation is indicated either when a patient has non-
functioning ovaries or when ovaries are not present. Other
patients requiring donor oocytes are women at high risk of
having children with genetic defects and those in' whom
several in virro fertilisation (IVF) cycles have not been success-
ful in retrieving adequate quality oocytes and in whom ulua-
sonography shows that the ovaries are inaccessible to oocyte
pick-up. Other women who qualify for oocyte donation are
those with congenital defects and patients who suffer from'
premature ovarian failure or who have the resistant ovary
syndrome. These women, who constitute approximately 5 -
10% of an IVF population, can now be treated by oocyte
donation.
The first report of a successful pregnancy using this proce-
dure was published by Lurjen er al.' in 1984. They established
and maintained a pregnancy in a patient with primary ovarian
failure using IVF and embryo donation.
The main problem in these patients has been to prime the
endometrium with exogenous oesuogen and progesterone suffi- .
ciently to make it receptive to implantation. With the availabi-
lity of 'spare' oocytes from consenting patients in our IVF
programme and the experience we have gained with primate
and human oocyte and embryo donation the abovementioned
groups of patients can now be treated successfully.
Case report
A 38-year-old nulliparous patient had been diagnosed as having
premature menopause at the age of 22 years. She was treated
for many years with hormone replacement therapy to prevent
early bone loss and changes in the lipoprotein metabolism. On
repeat hormonal screening the luteinising hormone level was
found to be 44,8 mIU, follicle-stimulating hormone 54 mIU
and .17a-hydroxyprogesterone 0,4 mIU; progesterone was
non-detectable. A chromosomal analysis was repeated and she
was found to be a 46,XX normal female. A laparoscopy was
performed and this showed a normal size anteverted uterus
with normal fallopian tubes but streak ovaries. Ovarian biopsy
was performed bilaterally and histological examination of the
specimens showed no primordial follicles. The antinuclear
factor was negative.
A prospective donor was recruited from the IVF programme;
she was prepared to donate 3 oocytes should we retrieve more
than 10 at the time of laparoscopy. This donor was matched to
the phenotypic characteristics of the recipient in respect of
colour of hair and eyes and approximate body build. The
donor and her spouse consented to this procedure. At the
beginning of the IVF cycle of the donor we started the
recipient on oestradiol valerate orally in slowly increasing
doses to mimic a normal proliferative phase (Fig. 1). On day
15 of her cycle the endometrial thickness was 13 mm.
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Fig. 1. Scheme of oestrogen medication to induce endometrial
proliferation.
On the day the donor received her human chorionic gona-
dotrophin (HCG) injection, the recipient was started on proge-
sterone supplementation (medroxyprogesterone acetate) to
induce the endometrium to change into the secretory phase.
At laparoscopy 14 oocytes were retrieved from the donor and 3
of these were inseminated with the recipient's husband's sperm.
All 3 oocytes cleaved after 48 hours into the 4-cell stage and
were transferred mto the uterus of the recipient using a
Wallace embryo transfer catheter. The recipient's level of the
f:l-subunit ofHCG on day 21 of the cycle was 15,7 mIU/l and
rose rapidly to 95,8 mID/l on day 24 and 920,0 mID/l on day
29. Ultrasonography on day 38 of the cycle showed 2 sacs but
no fetal hean activity. Ultrasonography was repeated on day
45 when a triplet pregnancy was diagnosed with 3 fetal heans
present.
The pregnancy was maintained using rising doses of oestra-
diol valerate (increased by 2 mg per week of pregnancy to a
maximum of 24 mg daily in the 8th week). At the same time
medroxyprogesterone acetate was also increased to a maximum
of 100 mg per day, then reduced from the 8th week of
pregnancy until both medications were fmally stopped by the
14th week of pregnancy.
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The pregnancy proceeded well without any hormonal sup-
port. During the. 34th week the patient developed pre-eclamptic
toxaemia and was delivered by caesarean section at the end of
this week of 3 healthy babies - 2 boys and I girl.
Discussion
Oocyte and possible embryo donation opens a completely new
door in the treatment of infertility. Although the technique of
donation of male gametes has been successfully applied for
many years through artificial insemination by donor sperm
(AID), only with the regular successful use of IVF are female
gametes now also available in sufficient numbers to allow for
an oocyte donation programme.2-4 The records of only a few
such pregnancies have been published world-wide and the one
described above is the first for the RSA. Although IVF
techniques have progressed sufficiently to permit access to a
relatively large pool of oocytes, there will always be difficulty
in retrieving oocytes, which remain less accessible than male
gametes.
The ethical.and moral problems of this procedure are of the
same magnitude as and comparable with AID, and will there-
fore probably be acceptable to the majority of patients. The
legality of oocyte donation has fortunately been addressed
adequately by the latest amendment to the Human Tissue Act,
which regulates gamete donation and therefore includes the
donation of oocytes. A child born from this procedure will be
legally the child of the consenting parents as defined by the
Child Care Act. .
From an obstetric point of view it was hoped that this
pregnancy would proceed without major problems to an ad-
vanced stage of gestation. This feeling was supported by the
fact that it now seems certain that relaxin is produced by the
ovary··5 and in a patient with non-functioning ovaries the
relaxin level should stay low and not cause softening and
dilating of cervix during pregnancy; in a multiple pregnancy
particularly this might induce premature labour. Our patient
was delivered by caesarean section because of rapidly develop-
ing pre-eclamptic toxaemia while the cervix was still closed.
From a pharmacological point of view it is known that
oestradiol valerate has no known teratogenic effects on the
fetus and that medroxyprogesterone acetate is not converted to
its androgenic precursors and therefore should not have any
androgenic effects on female offspring. If this procedure was
used on a regular basis, a natural progesterone, which unfortu-
nately is not available in this country, would be preferable to
medroxr,pr.ogesterone. The form of progesterone used by other
authors' IS the natural product and is administered in the
form of vaginal pessaries in doses of up to 200 mg!d.
It is concluded that oocyte donation closes the last gap in
the treatment of female infertility. The minimal precondition
is that the woman have a receptive uterus.
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